From Our Partners
Wednesday, June 22, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Kendall Leading DoD Anthrax Laboratory Review Team

by Global Biodefense Staff
June 9, 2015
DoD Anthrax Investigation - Frank Kendell

Frank Kendall (left), Deputy Defense Secretary Bob Work (center), Navy Cdr. Franca Jones (right) discuss the anthrax investigation during a briefing at the Pentagon. Image credit: Adrian Cadiz

Frank Kendall, the Department of Defense’s Undersecretary of Defense for Acquisition, Technology and Logistics, is leading a comprehensive review of DoD’s laboratory procedures, processes and protocols associated with inactivating spore-forming anthrax.

DoD Anthrax Investigation - Frank Kendell
Frank Kendall (left), Deputy Defense Secretary Bob Work (center), Navy Cdr. Franca Jones (right) discuss the anthrax investigation during a briefing at the Pentagon. Image credit: Adrian Cadiz

Speaking with Pentagon reporters last week, Kendall said he is assembling a team of government and private-sector experts to examine the anthrax spore inactivation processes.

“They will report preliminary findings and recommendations by the end of June,” he said.

According to Kendall, the final report will also depend upon the completion of the separate Center of Disease Control investigation, and will focus on two primary questions:  Why was there an incomplete inactivation of the spore-forming anthrax samples; and why testing mechanisms to ensure the procedures to inactivate the anthrax failed.

“Across the country,” Kendall said, “there are hundreds of labs that work with anthrax. As part of this mission, DoD ships inactivated or dead anthrax samples to laboratories as well as to industry, academia and other federal laboratories to help develop countermeasures and for other purposes.”

The inactivation process requires the samples to be irradiated with gamma rays, he said, then checked to ensure they are dead, and the CDC investigation is carefully examining why those two steps failed.

As part of DoD’s review of these processes, Kendall said more than 400 batches are being tested to determine how many lots were not completely inactivated.

“So far, at least four batches, or lots, have been found to have live spores present,” he said.

As additional lots are identified that were not fully inactivated, he said, labs are also being identified that received the samples, and this takes time. “So the numbers are likely to change and grow as we know more,” Kendall said.

Article adapted from original by DoD News.

From Our Partners
Tags: AnthraxBioterrorism

Related Posts

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
masked medical laboratory technician waits on samples to process in a biocontainment lab
Biosecurity

Design Phase Kicks Off for New $750M Wadsworth Public Health Laboratory

May 1, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Load More

Latest News

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Biodefense Headlines – 16 June 2022

Biodefense Headlines – 16 June 2022

June 16, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC